No Data
No Data
Oruka Therapeutics Completes Merger With ARCA Biopharma, Begins Trading Under ORKA, Appoints CRISPR CEO as Chairman
Express News | Oruka Therapeutics Announces Closing of Merger With ARCA Biopharma and Previously Announced Private Placement of $275 Million
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
ARCA Biopharma To Carry Out 1-for-12 Reverse Stock Split On September 3rd, 2024
ARCA Biopharma Announces Completion Of Merger With Oruka Therapeutics And Implementation Of Reverse Stock Split >ABIO
Stocks Ex-Dividend September 3